3-Ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydroindol-4-one

Catalog No. :
ACQIGZ860
CAS No. :
7416-34-4
Molecular Formula :
C16H24N2O2
Molecular Weight :
276.38

IUPAC Name:3-ethyl-2-methyl-5-(morpholinomethyl)-1,5,6,7-tetrahydro-4H-indol-4-one

3-Ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydroindol-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$547.00Login to see priceInquiryInquiry
100mg98%$657.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydroindol-4-one
IUPAC Name3-ethyl-2-methyl-5-(morpholinomethyl)-1,5,6,7-tetrahydro-4H-indol-4-one
Molecular FormulaC16H24N2O2
Molecular Weight276.38
SMILESO=C1C2=C(NC(C)=C2CC)CCC1CN3CCOCC3
InChI KeyKLPWJLBORRMFGK-UHFFFAOYSA-N
SynonymRT3Y3QMF8N | AB00514709_07 | L001248 | 3-Ethyl-2-methyl-5-morpholin-4-ylmethyl-1,5,6,7-tetrahydro-indol-4-one ( Molindone) | indol-4(5h)-one | UNII-RT3Y3QMF8N | AB00514709 | NCGC00162218-01 | SPBio_003100 | Molindone (INN) | 3-ethyl-2-methyl-5-(morpholin-
CAS No.7416-34-4
PubChem CID23897

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACQIGZ860 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFOZU698 route compound structure diagram
    ACFOZU6985625-90-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQIGZ860 route product structure diagram
    ACQIGZ8607416-34-4
Inquiry

2. ACQIGZ860 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQIGZ860 route product structure diagram
    ACQIGZ8607416-34-4
Inquiry

Comments (0)